PIK3CA and breast cancer: The present study describes somatic mutations detected by NGS using a custom panel in a series of 12 cases of invasive ductal BC resistant or refractory to systemic therapy. The mutations obtained were located in the TP53, PIK3CA, PTEN and ARID1A genes, among others (Figure 1).